J. DOUGLAS THORNTON

TitleAssistant Professor
InstitutionUniversity of Houston
DepartmentPharmaceutical Health Outcomes and Policy
AddressHealth 2 4849 Calhoun Road, Room 4053
Houston, TX 77204-5037
Houston TX 77204-5047
vCardDownload vCard

    Collapse Bibliographic 
    Collapse selected publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
    Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
    PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Rizk E, Kaur N, Duong PY, Fink E, Wanat MA, Thornton JD, Kim MP. Impact of automated alerts on discharge opioid overprescribing after general surgery. Am J Health Syst Pharm. 2024 Jul 01. PMID: 38946099.
      Citations:    Fields:    
    2. Olateju OA, Mgbere O, Thornton JD, Zeng Z, Essien EJ. Disparities in Survival Outcomes Among Patients With Metastatic Melanoma in Texas: Implications for Policy and Interventions in the Era of Immune Checkpoint Inhibitors. Am J Clin Oncol. 2024 Nov 01; 47(11):517-525. PMID: 38937888.
      Citations:    Fields:    Translation:Humans
    3. Thornton JD, Varisco T, Patel H, Shrestha M, Wanat M, Schaefer E, Leslie D, Zhao H, Saadi RA, Shen C. Characterising incident opioid use among incident users of prescription sedative hypnotics: A national cohort study. BMJ Open. 2024 May 30; 14(5):e082339. PMID: 38816043; PMCID: PMC11138274.
      Citations:    Fields:    Translation:Humans
    4. Olateju OA, Shen C, Thornton JD. The Affordable Care Act and income-based disparities in health care coverage and spending among nonelderly adults with cancer. Health Aff Sch. 2024 May; 2(5):qxae050. PMID: 38812986; PMCID: PMC11135644.
      Citations:    
    5. Huang Y, Coggins TM, Cirildo S, Gandy C, Aparasu RR, Thornton JD, Huang Y, Coggins TM, Cirildo S, Gandy C, Aparasu RR, Thornton JD. Patients' willingness to pay for naloxone: A national cross-sectional survey of prescription opioid users with chronic pain in the United States. J Am Pharm Assoc (2003). 2024 May-Jun; 64(3):102062. PMID: 38432479.
      Citations:    Fields:    Translation:Humans
    6. Shen C, Thornton JD, Li N, Schaefer E, Zhou S, Kawasaki S, Pameijer C, Leslie D. Opioid and Non-Opioid Pharmacotherapy Use for Pain Management Among Privately Insured Pediatric Patients With Cancer in the United States. Oncologist. 2024 Feb 02; 29(2):176-184. PMID: 37944042; PMCID: PMC10836308.
      Citations:    
    7. Thornton JD, Varisco T, Bhatt M Econ P, Olateju O, Shrestha M, Shen C. Productivity Loss Among Opioid and Benzodiazepine Users in the United States: A Medical Expenditure Panel Survey From 2010 to 2019. J Occup Environ Med. 2024 Mar 01; 66(3):226-233. PMID: 38151973; PMCID: PMC10922134.
      Citations:    Fields:    Translation:Humans
    8. Tata V, Al Saadi R, Cho SK, Varisco TJ, Wanat M, Thornton JD. Physician perspective on the implementation of risk mitigation strategies when prescribing opioid medications: a qualitative analysis. BMC Health Serv Res. 2023 Oct 31; 23(1):1185. PMID: 37907915; PMCID: PMC10617230.
      Citations:    Fields:    Translation:Humans
    9. Wang EM, Varisco TJ, Thornton JD, Varkey DA, Wanat MA. Student-led podcasts to enhance literature evaluation skills. Curr Pharm Teach Learn. 2023 Nov; 15(11):968-973. PMID: 37714755.
      Citations:    Fields:    
    10. Olateju OA, Zeng Z, Thornton JD, Mgbere O, Essien EJ. Management of metastatic melanoma in Texas: disparities in the utilization of immunotherapy following the regulatory approval of immune checkpoint inhibitors. BMC Cancer. 2023 Jul 13; 23(1):655. PMID: 37442992; PMCID: PMC10339559.
      Citations:    Fields:    Translation:Humans
    11. Tata V, Majd Z, Talwar A, Bapat S, Cruz A, Essien JE, Thornton JD. Differences in Perceived Threat and Efficacy in Managing Opioid Use Disorder versus Alcohol Use Disorder. Subst Use Misuse. 2023; 58(10):1187-1195. PMID: 37271735.
      Citations:    
    12. El-Desoky R, De La Cruz A, Thornton JD, Wanat MA, Varkey D. Identifying predictors of generalized anxiety among student pharmacists in response to the COVID-19 pandemic. Curr Pharm Teach Learn. 2023 01; 15(1):34-42. PMID: 36898886; PMCID: PMC9970934.
      Citations: 1     Fields:    Translation:HumansPHPublic Health
    13. Rizk E, Yuan F, Zheng F, Fink E, Kaur N, Tran AT, Iso T, Mohyuddin NG, Thekdi AA, Jackson GL, Wanat MA, Thornton JD, Swan JT. Optimization of Opioid Discharge Prescriptions Following Thyroid and Parathyroid Surgery. Otolaryngol Head Neck Surg. 2023 Jul; 169(1):176-184. PMID: 36040827.
      Citations:    
    14. Varisco TJ, Downs CG, Sansgiry SS, Al Saadi R, Hastings T, Thornton JD. Parents' intention to have their child vaccinated at a community pharmacy: A national cross-sectional survey. J Am Pharm Assoc (2003). 2023 Mar-Apr; 63(2):511-517.e8. PMID: 36376213; PMCID: PMC9558631.
      Citations:    Fields:    Translation:HumansPHPublic Health
    15. Huang Y, Lyu N, Gohil S, Bapat S, Essien EJ, Thornton JD. Intention to get naloxone among?patients prescribed opioids for chronic pain. Harm Reduct J. 2022 Sep 22; 19(1):104. PMID: 36138420; PMCID: PMC9502607.
      Citations:    
    16. Anyanwu P, Varisco TJ, Wanat MA, Bapat S, Claborn K, Thornton JD. Comparing Two Databases to Identify Access to Buprenorphine Treatment for Opioid Use Disorder. J Pain Palliat Care Pharmacother. 2022 Jun 01; 1-9. PMID: 35648731.
      Citations:    Fields:    
    17. Cho SK, Jun H, Varisco TJ, Lam J, Romley JA, Li J, Thornton JD. Association of cash payment with intensity of opioid prescriptions. J Am Pharm Assoc (2003). 2022 Jul-Aug; 62(4):1224-1231.e5. PMID: 35227642.
      Citations:    
    18. Earla JR, Hutton GJ, Thornton JD, Chen H, Johnson ML, Aparasu RR. Factors associated with oral fingolimod use over injectable disease- modifying agent use in multiple sclerosis. Explor Res Clin Soc Pharm. 2021 Jun; 2:100021. PMID: 35481133; PMCID: PMC9031432.
      Citations:    
    19. Iloabuchi C, Aboaziza E, Zhao X, Thornton JD, Dwibedi N. College Students' Perceptions About Prescription Drug Misuse Among Peers. Am Health Drug Benefits. 2021 Mar; 14(1):29-38. PMID: 33841623; PMCID: PMC8025926.
      Citations:    
    20. Thornton JD, Varisco TJ, Downs CG. Factors associated with the use of the prescription monitoring program by prescribers and pharmacists in Texas. Pharmacoepidemiol Drug Saf. 2021 04; 30(4):492-503. PMID: 33458926.
      Citations:    Fields:    Translation:Humans
    21. Shen C, Thornton JD, Newport K, Schaefer E, Zhou S, Yee NS, Dodge D, Leslie D. Trends and patterns in the use of opioids among metastatic breast cancer patients. Sci Rep. 2020 12 10; 10(1):21698. PMID: 33303832; PMCID: PMC7729956.
      Citations:    
    22. Thornton JD, Varisco TJ, Bapat SS, Downs CG, Shen C. Impact of COVID-19 Related Policy Changes on Buprenorphine Dispensing in Texas. J Addict Med. 2020 12; 14(6):e372-e374. PMID: 33031213; PMCID: PMC8194032.
      Citations: 3     Fields:    Translation:HumansPHPublic Health
    23. Earla JR, Hutton GJ, Thornton JD, Chen H, Johnson ML, Aparasu RR. Comparative Adherence Trajectories of Oral Fingolimod and Injectable Disease Modifying Agents in Multiple Sclerosis. Patient Prefer Adherence. 2020; 14:2187-2199. PMID: 33177813; PMCID: PMC7649232.
      Citations: 2     
    24. Wanat MA, Varkey DA, Sulaica EM, Thornton KA, Thornton JD. Does Social Desirability Influence Preceptors' Completion of Student Experiential Evaluations? Am J Pharm Educ. 2020 09; 84(9):ajpe7949. PMID: 33012802; PMCID: PMC7523664.
      Citations:    Fields:    Translation:Humans
    25. Varisco TJ, Downs CG, Rathburn KR, Fleming ML, Thornton JD. Applying the capability, opportunity, motivation, and behavior model to identify opportunities to increase pharmacist comfort dispensing naloxone in Texas: A structural equation modeling approach. Int J Drug Policy. 2020 09; 83:102827. PMID: 32589581.
      Citations:    
    26. Earla JR, Hutton GJ, Thornton JD, Aparasu RR. Factors Associated with Prescribing Oral Disease Modifying Agents in Multiple Sclerosis: a Real-world Analysis of Electronic Medical Records. Mult Scler Relat Disord. 2020 Oct; 45:102334. PMID: 32629400.
      Citations:    Fields:    Translation:Humans
    27. Downs CG, Varisco TJ, Bapat SS, Shen C, Thornton JD. Impact of COVID-19 related policy changes on filling of opioid and benzodiazepine medications. Res Social Adm Pharm. 2021 01; 17(1):2005-2008. PMID: 33317769; PMCID: PMC7738763.
      Citations: 4     Fields:    Translation:Humans
    28. Shen C, Thornton JD, Gu D, Dodge D, Zhou S, He W, Zhao H, Giordano SH. Prolonged Opioid Use After Surgery for Early-Stage Breast Cancer. Oncologist. 2020 10; 25(10):e1574-e1582. PMID: 32390251; PMCID: PMC7543235.
      Citations: 4     Fields:    Translation:Humans
    29. Earla JR, Thornton JD, Hutton GJ, Aparasu RR. Marginal Health Care Expenditure Burden Among U.S. Civilian Noninstitutionalized Individuals with Multiple Sclerosis: 2010-2015. J Manag Care Spec Pharm. 2020 Jun; 26(6):741-749. PMID: 32463779; PMCID: PMC10391019.
      Citations: 1     Fields:    Translation:Humans
    30. Adil MQ, De La Cruz A, Thornton JD, Wanat MA. Incidence of Chronic Opioid Use in Previously Opioid-Na?ve Patients Receiving Opioids for Analgesia in the Intensive Care Unit. Fed Pract. 2020 Apr; 37(4):170-176. PMID: 32322148; PMCID: PMC7173643.
      Citations: 1     
    31. Thornton JD, Anyanwu P, Tata V, Al Rawwad T, Fleming ML. Differences between pharmacists' perception of counseling and practice in the era of prescription drug misuse. Pharm Pract (Granada). 2020 Jan-Mar; 18(1):1682. PMID: 32206140; PMCID: PMC7075424.
      Citations: 1     
    32. Imarhia F, Varisco TJ, Wanat MA, Thornton JD. Prescription drug disposal: Products available for home use. J Am Pharm Assoc (2003). 2020 Jul - Aug; 60(4):e7-e13. PMID: 32067882.
      Citations: 3     Fields:    Translation:Humans
    33. Fernandez J, Thornton JD, Rege S, Lewing B, Bapat S, Xu Q, Fleming ML. Prescribers' perceptions on the impact of hydrocodone rescheduling on geriatric pain management: A qualitative study. J Opioid Manag. 2018 Sep/Oct; 14(5):317-326. PMID: 30387855.
      Citations:    Fields:    Translation:Humans
    34. Thornton JD, Dwibedi N, Scott V, Ponte CD, Ziedonis D, Sambamoorthi N, Sambamoorthi U. Predictors of Transitioning to Incident Chronic Opioid Therapy Among Working-Age Adults in the United States. Am Health Drug Benefits. 2018 Feb; 11(1):12-21. PMID: 29692877; PMCID: PMC5902762.
      Citations:    
    35. Thornton JD, Goyat R, Dwibedi N, Kelley GA. Health-related quality of life in patients receiving long-term opioid therapy: a systematic review with meta-analysis. Qual Life Res. 2017 08; 26(8):1955-1967. PMID: 28255745; PMCID: PMC5511070.
      Citations:    
    36. Thornton JD, Lyvers E, Scott VGG, Dwibedi N. Pharmacists' readiness to provide naloxone in community pharmacies in West Virginia. J Am Pharm Assoc (2003). 2017 Mar - Apr; 57(2S):S12-S18.e4. PMID: 28163027; PMCID: PMC5352525.
      Citations:    
    37. Thornton JD, Deb A, Murray PJ, Kelly KM. Car Seat Safety: Typologies of Protective Health and Safety Behaviors for Mothers in West Virginia. Matern Child Health J. 2017 02; 21(2):326-334. PMID: 27435731; PMCID: PMC5247407.
      Citations:    
    38. Thornton JD, Agarwal P, Sambamoorthi U. Use of selective-serotonin reuptake inhibitors and platelet aggregation inhibitors among individuals with co-occurring atherosclerotic cardiovascular disease and depression or anxiety. SAGE Open Med. 2016; 4:2050312116682255. PMID: 28348738; PMCID: PMC5354183.
      Citations:    
    39. Thornton JD. Re: Saunders R, Lian J, Karolicki B, Valentine W. The cost-effectiveness and budget impact of stepwise addition of bolus insulin in the treatment of type 2 diabetes: evaluation of the FullSTEP trial. J Med Econ 2014;17(12):827-36. J Med Econ. 2015 Jun; 18(6):433-4. PMID: 25586202.
      Citations:    
    THORNTON's Networks
    Click the
    Explore
    buttons for more information and interactive visualizations!
    Concepts (124)
    Explore
    _
    Co-Authors (9)
    Explore
    _
    Similar People (58)
    Explore
    _
    Same Department Expand Description
    Explore
    _